rxstat › Drug prices › Hydrochlorothiazide Enalapril

Hydrochlorothiazide Enalapril (Vaseretic) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Hydrochlorothiazide Enalapril 8 mg / 25 mg tablet costs about $1.07 to $1.67 per tablet on public drug plan price lists across 7 provinces, before the pharmacy's dispensing fee.

Hydrochlorothiazide Enalapril has no current shortage reported in Canada. It has been in shortage before; the history is below.

Price by province

Strength and formBCABSKMBONNBNSPENL
8 mg / 25 mg Tabletper tablet$1.67$1.29$1.50$1.55–$1.07–$1.07$1.64
Plan coverageCoveredCoveredCoveredPrice listNot coveredCoveredNot coveredPrice listPrice list

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

British Columbia: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · MRK
    DIN 00657298 · $1.67/tablet · Covered
Alberta: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · ORC
    DIN 00657298 · $1.29/tablet · Covered
Saskatchewan: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · ORG
    DIN 00657298 · $1.50/tablet · Covered
Manitoba: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · ORG
    DIN 00657298 · $1.55/tablet · Price list
Ontario: 2 products
  • Vaseretic 4 mg / 12.5 mg Tablet · Merck Frosst Canada Ltd.
    DIN 02242826 · no listed price · Not covered
  • Vaseretic 8 mg / 25 mg Tablet · Organon Canada Inc.
    DIN 00657298 · no listed price · Not covered
New Brunswick: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · ORG
    DIN 00657298 · $1.07/tablet · Covered
Nova Scotia: 2 products
  • Vaseretic 8 mg / 25 mg Tablet · ORG
    DIN 00657298 · no listed price · Not covered
  • Vaseretic 4 mg / 12.5 mg Tablet · FRS
    DIN 02242826 · no listed price · Not covered
Prince Edward Island: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · MSD
    DIN 00657298 · $1.07/tablet · Price list
Newfoundland and Labrador: 1 product
  • Vaseretic 8 mg / 25 mg Tablet · MFC
    DIN 00657298 · $1.64/tablet · Price list

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · BC PharmaCare Low Cost Alternative list (Nov 5, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026) · New Brunswick Drug Plans Formulary (Nov 1, 2026) · Nova Scotia Pharmacare Formulary (Nov 1, 2026) · PEI Pharmacare Maximum Reimbursable Price List (Nov 24, 2026) · Newfoundland and Labrador Interchangeable Drug Products Formulary (Oct 1, 2026) · Manitoba Drug Interchangeability Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
7

Reports by product

The DIN is printed on your prescription label.

Avoided
VASERETIC
25MG 8MG · TABLET · ORGANON CANADA INC.
DIN 00657298 · ended Aug 21, 2024 · Delay in shipping of the drug.
Resolved
VASERETIC
25MG 8MG · TABLET · ORGANON CANADA INC.
DIN 00657298 · ended Jan 31, 2022 · Delay in shipping of the drug.
Resolved
VASERETIC
8MG 25MG · TABLET · MERCK CANADA INC
DIN 00657298 · ended May 25, 2020 · Delay in shipping of the drug.
Resolved
VASERETIC
25MG 8MG · TABLET · MERCK CANADA INC
DIN 00657298 · ended Apr 25, 2019 · Delay in shipping of the drug.
Resolved
VASERETIC
25MG 8MG · TABLET · MERCK CANADA INC
DIN 00657298 · ended Mar 14, 2019 · Demand increase for the drug.
Resolved
VASERETIC
25MG 8MG · TABLET · MERCK CANADA INC
DIN 00657298 · ended Dec 20, 2017 · Delay in shipping of the drug.
Resolved
VASERETIC
25MG 8MG · TABLET · MERCK CANADA INC
DIN 00657298 · ended Jun 6, 2017 · Delay in shipping of the drug.

What's happening

There are no active shortage reports for Hydrochlorothiazide Enalapril. Health Canada has 7 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Hydrochlorothiazide Enalapril is classified under “ACE INHIBITORS, COMBINATIONS” (ATC C09BA).

Recent changes

Common questions

How much does Hydrochlorothiazide Enalapril cost in Canada?

Hydrochlorothiazide Enalapril 8 mg / 25 mg tablet costs about $1.07 to $1.67 per tablet on public drug plan price lists across 7 provinces, before the pharmacy's dispensing fee.

Is Hydrochlorothiazide Enalapril covered by provincial drug plans?

On the public plans' own lists: British Columbia: covered; Alberta: covered; Saskatchewan: covered; Manitoba: price list; Ontario: not covered; New Brunswick: covered; Nova Scotia: not covered; Prince Edward Island: price list; Newfoundland and Labrador: price list. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Hydrochlorothiazide Enalapril be back in stock in Canada?

Hydrochlorothiazide Enalapril has no active shortage; supply is normal per Health Canada reports.

Why is Hydrochlorothiazide Enalapril in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (ace inhibitors, combinations)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.